In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Drug:  tipifarnib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00535, E2902, U10CA021115, U10CA180820, ECOG-E2902, NCT00093470

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 70 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004372, NCT00093990

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003976, R115777-INT-11, JRF-R115777-INT-11, NCT00005648

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067864, SUMC-NCI-38, NCI-38, 38, NCT00005846

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01442, MC0131, WSU-C-2679, MAYO-MC0131, NCI-5599, CDR0000331694, N01CM62205, 5599, NCT00070252

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID02-126, NCT00050986

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: NCI-2012-02862, 2003-0563, 6625, N01CM62202, MDA-2003-0563, NCI-6625, NCT00096122

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00114, CDR0000409695, 2003-0992, 7004, N01CM62202, N01CM17003, P30CA016672, MDA-2003-0992, NCI-7004, NCT00100750

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00676, CDR0000476286, NABTC-05-02, U01CA137443, ABTC-05-02, NCT00335764

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00239, CDR0000543434, 06-12-487, 7868, P30CA013330, N01CM62202, N01CM62204, NYCC-06-12-487, NCT00470301

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-03021, PBTC-014, U01CA081457, NCT00079339

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067632, NYU-9861, JRF-R115777-USA-8B, NCI-G00-1714, NCT00005041

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02335, FCCC-00005, NCI-45, CDR0000067859, 45, NCT00005843

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: FCCC-99031, CDR0000067866, NCI-20, FCC-RRC-56-99, 20, NCT00005848

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067888, NABTC-9901, NCT00005859

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067978, U01CA069912, P30CA015083, 982401, MAYO-982401, NCI-T99-0072, T99-0072, NCT00005989

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MCC-12162, JRF-R115777-INT-10, MCC-IRB-5623, NCI-G00-1861, NCT00006376

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12516, NIH-2030, MCC-12137, MCC-IRB-5442, NCT00012350

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCC-12516, MCC-IRB-6028, NCI-2030, 2030, NCT00021203

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Child
Sponsor: NCI
Protocol IDs: NCI-2012-01861, AAML0122, U10CA098543, CDR0000068788, COG-AAML0122, NCT00025038

22.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 3 to 25
Sponsor: NCI
Protocol IDs: 010222, 01-C-0222, NCI-01-C-0222, NCI-T99-0090, NCT00029354, T99-0090, NCT00021541

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02423, RTOG-PA-0020, RTOG-DEV-1003, CDR0000068986, U10CA021661, NCT00026104

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02980, UMGCC 0116, U01CA069854, U01CA070095, JHOC-J0255, MSGCC-U5400, MSGCC-0116, NCI-1754, 1754, NCT00027872

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03158, J0252, U01CA070095, U01CA069854, JHOC-J0252, MSGCC-0150, NCI-5689, 5689, NCT00045396
1    
New Search